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Introduction: Epigenetics is playing a decisive role in the
regulation of gene expression. Furthermore, pathological
epigenetic changes have already been associated with
various diseases, especially cancer. However, few data are
so far available about epigenetic modiﬁcations in athero-
sclerotic lesions. Therefore, we investigated histone
methylation and acetylation in different stages of athero-
sclerosis in patients with carotid artery stenosis.
Methods: Carotid plaques (n ¼ 120) from our biobank were
classiﬁed histologically according to AHA and divided as
early (type IeIII, n ¼ 60) or advanced (type VeVII, n ¼ 60)
stage of atherosclerosis. Twelve healthy vessels served as
controls. Expression of histone methyl and acetyl-
transferases were analysed by SYBRgreen-based real-time
RT-PCR. Immunohistochemistry and western blotting were
performed to quantify expression at protein level and to
associate histone methylation with the individual cells
within the atherosclerotic plaques.
Results: In atherosclerosis, methylation of H3K4 was unal-
tered. In contrast methylation of H3K9 and H3K27 were
signiﬁcantly decreased, compared to control arteries.
Expression of H3K4 was increased and H3K9 decreased in
smooth muscles, whereas H3K9 and H3K27 were reduced in
inﬂammatory cells in advanced versus early atherosclerosis.
MML2 and G9a signiﬁcantly increased in advanced versus
early atherosclerosis, and a signiﬁcant decrease in expres-
sion of G9a was observed between controls and early
stages. Increased histone acetylation was observed on H3K9
and H3K27 in SMCs in advanced atherosclerotic lesions
compared to healthy vessels, acetylation of H3 at position
K9 in SMCs and macrophages was associated with plaque
progression. Expression of acetyltransferase GCN5L and
MYST1 correlated with severity of atherosclerosis.
Conclusion: The extent of histone methylation and acetyla-
tion, as well the expression of corresponding transferases
were signiﬁcantly altered in atherosclerotic lesions and were
signiﬁcantly associated with the progression of atheroscle-
rosis, thus suggesting an important contribution of epige-
netic mechanisms to plaque progression and vulnerability.
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College London, UKIntroduction: Vascular complications associated with sys-
temic sclerosis (SSc) including pulmonary arterial hyper-
tension (PAH-SSc), result from endothelial damage and loss
of barrier function. The causes of endothelial dysfunction
are unclear, but endothelial integrity is likely to be signiﬁ-
cantly diminished in SSc. Endothelial progenitor cells (EPCs)
derived from peripheral blood mononuclear cells (PBMCs)
express endothelial and haematopoietic markers. It is
thought they home to sites of vascular injury and differ-
entiate into endothelial cells and restore the barrier. In SSc
patients circulating levels of EPCs are reduced. This study
aimed to: (i) Develop a robust method to isolate, grow and
characterise healthy control (HC) and SSc EPCs from PBMCs.
(ii) Compare the cellular functions of EPCs to mature
endothelial cells. (iii) Elucidate the functional role of EPCs in
SSc vasculopathy.
Methods: Peripheral blood was taken from HC (n ¼ 10) and
SSc donors (n ¼ 10). EPCs were cultured from PBMCs. EPCs
were characterised by ﬂow cytometry, then EPCs and hu-
man pulmonary artery endothelial cells (hPAECs) were
seeded into transwell inserts and grown to conﬂuence. Cells
were incubated with TNFa (10 ng/ml), and their capacity to
form biological barriers and support immune cell inﬂux was
assessed using FITC-albumin (0.5 mg/ml) and neutrophil
transmigration. We further assessed the responses of EPCs
to TNFa stimulation by ELISA to quantify pro-inﬂammatory
cytokine release.
Results: We demonstrate that EPCs, characterised by ﬂow
cytometry to be CD34+/CD31+/VEGFR2+/CD105+ and
CD133+, can form biological barriers with similar capabil-
ities as mature hPAECs in vitro. TNFa signiﬁcantly enhanced
permeability of EPCs (P < 0.05) and hPAECs (P < 0.05)
monolayers. Mixed cultures of 10% SSc-EPCs and 90%
mature PAECs signiﬁcantly enhanced endothelial perme-
ability compared to HC-EPC/PAECs mixed cultures. Consis-
tent with EPCs possessing similar cellular activities as
mature endothelial cells, TNFa stimulated neutrophil
transmigration in monolayers of EPCs (P < 0.05) and
hPAECs (P < 0.05) and enhanced the secretion of IL-8 in
both EPCs (P < 0.01) and hPAECs (P < 0.05).
Conclusion: We have demonstrated that endothelial pro-
genitors can maintain an endothelial barrier consistent with
that observed by mature hPAECs in vitro; established that
endothelial barriers consisting of both EPCs and mature
endothelial cells are dysfunctional in SSc; and ﬁnally, shown
that EPCs respond to TNFa in a similar manner to mature
PAECs, secreting pro-inﬂammatory cytokines such as IL-8
and supporting neutrophil transmigration. The biological
function and importance of EPCs from SSc patients in vas-
culopathy, restoration and maintenance of the endothelial
barrier function remains unclear.
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